Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Mar 15, 2017

Accelerate Diagnostics Names Tom Brown to Board of Directors
TUCSON, Ariz., March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company's board of directors. His appointment is effective March 14, 2017. Brown's appointment adds over 30 years of medical diagnostics expertise to the company's board of directors. Beginning his career with the A...Read more

Feb 23, 2017

Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly fro...Read more

Feb 23, 2017

Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27th, 2017. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to...Read more

Dec 14, 2016

Accelerate Diagnostics to Present at the 35th Annual J.P. Morgan Healthcare Conference
TUCSON, Ariz., Dec. 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that it will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2017 at 11:00 a.m. PT. A live audio webcast of the presentation will be accessible from the investor portal of the company's w...Read more

Nov 22, 2016

Accelerate Diagnostics to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 30th
TUCSON, Ariz., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, President and Chief Executive Officer, is scheduled to present at the Piper Jaffray 28th Annual Healthcare Conference in New York City, NY on Wednesday, November 30th at 2:00 PM EST. A live audio webcast of the presentation wil...Read more

Oct 21, 2016

Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to review the results at 4:15...Read more

Jul 22, 2016

Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8
TUCSON, Ariz., July 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report second-quarter 2016 financial results on Monday, August 8th. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to review the results at 4:15 p.m. ET...Read more

Jul 11, 2016

Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit
TUCSON, Ariz., July 11, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the submission of a De Novo request for Evaluation of Automatic Class III Designation to the U.S. Food and Drug Administration (FDA) for its Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for positive blood culture s...Read more

Jun 15, 2016

William Blair & Company 36th Annual Growth Stock Conference

Jun 14, 2016

Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference
TUCSON, Ariz., June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the completion of clinical data collection intended for submission to the FDA in conjunction with its de novo 510k request for premarket clearance of the Accelerate Pheno™ system and Accelerate Pheno™ BC kit for positive blood ...Read more
1
2
3
...
6
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 22.85
+0.10
(0.44%)
9:33 AM ET on Mar 24, 2017
Day High: 22.91
Day Low:  22.75
Volume:    2,418
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates